| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Reneo Pharmaceuticals Inc (NASDAQ: RPHM)
RPHM Technical Analysis
5
| As on 9th Jun 2023 RPHM STOCK Price closed @ 8.93 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 3.84 & Strong Buy for SHORT-TERM with Stoploss of 6.76 we also expect STOCK to react on Following IMPORTANT LEVELS. |
RPHMSTOCK Price
| Open | 8.70 | Change | Price | % |
| High | 9.25 | 1 Day | 0.09 | 1.02 |
| Low | 8.70 | 1 Week | 0.75 | 9.17 |
| Close | 8.93 | 1 Month | -0.22 | -2.40 |
| Volume | 87314 | 1 Year | 2.01 | 29.05 |
| 52 Week High 10.50 | 52 Week Low 1.80 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| RPHM Daily Charts |
RPHM Intraday Charts |
Whats New @ Bazaartrend |
RPHM Free Analysis |
|
|
RPHM Important Levels Intraday
| RESISTANCE | 9.99 |
| RESISTANCE | 9.65 |
| RESISTANCE | 9.44 |
| RESISTANCE | 9.23 |
| SUPPORT | 8.63 |
| SUPPORT | 8.42 |
| SUPPORT | 8.21 |
| SUPPORT | 7.87 |
RPHM Forecast April 2024
| 4th UP Forecast | 17.77 |
| 3rd UP Forecast | 14.94 |
| 2nd UP Forecast | 13.18 |
| 1st UP Forecast | 11.43 |
| 1st DOWN Forecast | 6.43 |
| 2nd DOWN Forecast | 4.68 |
| 3rd DOWN Forecast | 2.92 |
| 4th DOWN Forecast | 0.09 |
RPHM Weekly Forecast
| 4th UP Forecast | 15.13 |
| 3rd UP Forecast | 13.14 |
| 2nd UP Forecast | 11.91 |
| 1st UP Forecast | 10.68 |
| 1st DOWN Forecast | 7.18 |
| 2nd DOWN Forecast | 5.95 |
| 3rd DOWN Forecast | 4.72 |
| 4th DOWN Forecast | 2.73 |
RPHM Forecast2024
| 4th UP Forecast | 27.24 |
| 3rd UP Forecast | 21.37 |
| 2nd UP Forecast | 17.74 |
| 1st UP Forecast | 14.11 |
| 1st DOWN Forecast | 3.75 |
| 2nd DOWN Forecast | 0.12 |
| 3rd DOWN Forecast | -3.51 |
| 4th DOWN Forecast | -9.38 |
Reneo Pharmaceuticals Inc ( NASDAQ USA Symbol : RPHM )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
RPHM Business Profile
Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as well as in Phase 1b clinical trial in patients with long-chain fatty acid oxidation disorders and glycogen storage disease type V. The company was incorporated in 2014 and is headquartered in San Diego, California. Address: 12230 El Camino Real, San Diego, CA, United States, 92130
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service